Nutrition Labels for Clinical AI: Principles for Buying and Building Trust

Here is the uncomfortable reality of buying clinical AI in 2026: hospitals are purchasing models faster than anyone can vet them, and most buyers have no standard way to ask the only question that matters, is this safe for my patients? The market's answer is borrowed from the grocery store. CHAI, the Coalition for Health AI, has been building a nutrition label for health AI, a standardized model card, plus a certification program for independent assurance labs that test the models. I think this is one of the most important developments in the field, and I want to give you the principles for using it, whether you are buying AI or building it.

A label does not tell you a model is good. It tells you what the model is, what it was tested on, and who checked. That is exactly the information you need to make your own call. Here is how I read one.

If a vendor cannot produce a model card that says what their AI is, who it is for, and how it was tested, you have learned the most important thing already. In every other high-stakes purchase, from a drug to a bridge bolt, the documentation is part of the product. Treat a missing label not as a paperwork gap but as a signal about how the thing was built and how much its makers want you to look closely.

The single most skipped line on any label is intended use, and it is the one that hurts people. A sepsis model validated in an academic ICU is not validated for your community hospital's medical floor, and a documentation tool tested on English-language visits is not tested on your interpreter-mediated ones. Read the intended-use line first, and if your setting is not in it, assume the performance numbers do not apply to you until proven otherwise.

Demand the population the model was tested on, then hold it up against the patients you actually serve. This is where equity lives or dies. A model that performs beautifully on the population it saw can quietly fail the groups it did not, and the failure usually lands on the people already getting less care. A good label names the tested population and breaks performance down across it. If it reports one headline number and no subgroups, that silence is itself the answer.

A metric with no denominator is marketing. Ninety-five percent accuracy sounds wonderful until you learn the condition occurs in two percent of patients, at which point a model that simply always says no scores ninety-eight. Push past the headline number to the base rate, the cost of a false positive versus a false negative, and how the metric behaves on the rare cases that were the whole reason you wanted the tool. The label should give you enough to do that arithmetic yourself.

Self-attestation is not assurance. The reason CHAI is standing up independent labs under an international testing standard, with mandatory conflict-of-interest disclosure, is that a developer grading its own homework is not evidence. On the organizational side, the Joint Commission launched a first-of-its-kind certification for the responsible use of AI, covering governance, monitoring, and transparency at the organization level. Prefer vendors whose models were checked by someone with nothing to gain, and build your own house to a standard someone could actually certify.

A label is a photograph, and the model keeps living after the shutter clicks. Populations shift, upstream data changes, and yesterday's validated tool becomes today's silent failure. Any label worth trusting includes a maintenance plan: who monitors performance, on what cadence, and what triggers a recheck. If nobody owns the model after go-live, the label is already out of date and you are flying blind.

How to place a vendor at a glance

When I boil all of that down, two questions do most of the work: how transparent is the vendor, and who independently checked. Plot those two against each other and the buying decision nearly makes itself.

The top-right is where you want to be. The bottom-left is where a surprising number of the tools being pitched into hospitals right now actually sit. Most of the market lives in the bottom-right, real transparency but no independent check, which is workable if you do your own diligence and quietly dangerous if you assume the label alone is enough.

The nutrition label and the assurance lab are not bureaucracy, they are the immune system this field has been missing. If you build AI, publish the label before someone makes you. If you buy it, refuse to purchase without one. And either way, learn to read the label like a clinician reads a chart: skeptically, specifically, and with the patient in mind. That habit will protect more people than any single model ever will.